Mycobacterium haemophilum infection after alemtuzumab treatment. uri icon

Overview

publication date

  • November 1, 2008

Research

keywords

  • Antibodies, Monoclonal
  • Antibodies, Neoplasm
  • Antineoplastic Agents
  • Communicable Diseases, Emerging
  • Immunosuppressive Agents
  • Mycobacterium Infections
  • Mycobacterium haemophilum
  • Skin Diseases, Bacterial

Identity

PubMed Central ID

  • PMC2630725

Scopus Document Identifier

  • 55549122672

Digital Object Identifier (DOI)

  • 10.1086/375690

PubMed ID

  • 18976587

Additional Document Info

volume

  • 14

issue

  • 11